參考文獻(xiàn)/References:
[1] MONT M A,CHERIAN J J,SIERRA R J,et al.Nontraumatic osteonecrosis of the femoral head:where do we stand today?A ten-year update[J].J Bone Joint Surg Am,2015,97(19):1604-1627.
[2] MONT M A,ZYWIEL M G,MARKER D R,et al.The natural history of untreated asymptomatic osteonecrosis of the femoral head:a systematic literature review[J].J Bone Joint Surg Am,2010,92(12):2165-2170.
[3] CHEN S B,HU H,GAO Y S,et al.Prevalence of clinical anxiety,clinical depression and associated risk factors in Chinese young and middleaged patients with osteonecrosis of the femoral head[J].PLoS One,2015,10(3):e0120234.
[4] MAGILL P,BLANEY J,HILL J C,et al.Impact of a learning curve on the survivorship of 4802 cementless total hip arthroplasties[J].Bone Joint J,2016,98B(12):1589-1596.
[5] 趙德偉,謝輝.成人股骨頭壞死保髖手術(shù)治療的策略及探討[J].中國修復(fù)重建外科雜志,2018,32(7):792-797.
[6] MONT M A,HUNGERFORD D S.Non-traumatic avascular necrosis of the femoral head[J].J Bone Joint Surg Am,1995,77(3):459-474.
[7] 中華人民共和國勞動(dòng)人事部,中國醫(yī)學(xué)科學(xué)院衛(wèi)生研究所.中華人民共和國國家標(biāo)準(zhǔn)體力勞動(dòng)強(qiáng)度分級(jí):GB3869-83[J].化工勞動(dòng)保護(hù),1999,20(5/6):15-16.
[8] GARDENIERS J W M.Report of the committee of staging and nomenclature[N/OL].ARCO NewsLetter,1993-10-14[2020-01-13].http://arco-intl.org/Newsletters/Gardeniers-1993-5-2/Gardeniers-1993.htm.
[9] 李子榮,劉朝暉,孫偉,等.基于三柱結(jié)構(gòu)的股骨頭壞死分型——中日友好醫(yī)院分型[J].中華骨科雜志,2012,32(6):515-520.
[10] LIEBERMAN J R,ENGSTROM S M,MENEGHINI R M,et al.Which factors influence preservation of the osteonecrotic femoral head?[J].Clin Orthop Relat Res,2012,470(2):525-534.
[11] TOMARU Y,YOSHIOKA T,SUGAYA H,et al.Hip preserving surgery with concentrated autologous bone marrow aspirate transplantation for the treatment of asymptomatic osteonecrosis of the femoral head:retrospective review of clinical and radiological outcomes at 6 years postoperatively[J].BMC Musculoskelet Disord,2017,18(1):292.
[12] 趙德偉,程亮亮.國內(nèi)股骨頭壞死保留髖關(guān)節(jié)手術(shù)治療的十年回顧[J].中華骨科雜志,2017,37(3):183-192.
[13] ZHAO D W,YU M,HU K,et al.Prevalence of nontraumatic osteonecrosis of the femoral head and its associated risk factors in the Chinese population:results from a nationally representative survey[J].Chin Med J(Engl),2015,128(21):2843-2850.
[14] YIN J M,LIU Z,ZHAO S C,et al.Relationship between the apolipoprotein AI,B gene polymorphism and the risk of non-traumatic osteonecrosis[J].Lipids Health Dis,2014(13):149.
[15] 崔立強(qiáng).中國大陸地區(qū)股骨頭壞死病因?qū)W調(diào)查及危險(xiǎn)因素初步分析[D].北京:北京協(xié)和醫(yī)學(xué)院,2014.
[16] 陳衛(wèi)衡.客觀評(píng)價(jià)介入治療在股骨頭壞死中的作用[J].中國實(shí)用醫(yī)藥,2008,3(28):172-173.
[17] 陳衛(wèi)衡,張磊,劉道兵,等.聯(lián)合微創(chuàng)手術(shù)治療股骨頭壞死的臨床研究[J].中國矯形外科雜志,2004,12(17):1287-1289.
[18] DING H,GAO Y S,CHEN S B,et al.Free vascularized fibular grafting benefits severely collapsed femoral head in concomitant with osteoarthritis in very young adults:a prospective study[J].J Reconstr Microsurg,2013,29(6):387-392.
[19] TETIK C,BA �瘙 塁 AR H,BEZER M,et al.Comparison of early results of vascularized and non-vascularized fibular grafting in the treatment of osteonecrosis of the femoral head[J].Acta Orthop Traumatol Turc,2011,45(5):326-334.
[20] ALI S A,CHRISTY J M,GRIESSER M J,et al.Treatment of avascular necrosis of the femoral head utilising free vascularised fibular graft:a systematic review[J].Hip Int,2014,24(1):5-13.
[21] PAPANAGIOTOU M,MALIZOS K N,VLYCHOU M,et al.Autologous(non-vascularised)fibular grafting with recombinant bone morphogenetic protein-7 for the treatment of femoral head osteonecrosis:preliminary report[J].Bone Joint J,2014,96-B(1):31-35.
[22] 李子榮.股骨頭壞死成功保髖新理念[J].中醫(yī)正骨,2018,30(10):1-3.
[23] 左偉,孫偉,高福強(qiáng),等.經(jīng)頭頸部開窗打壓植骨治療股骨頭已部分塌陷股骨頭壞死療效分析[J].中國修復(fù)重建外科雜志,2016,30(4):397-401.
[24] 李子榮.骨壞死[M].北京:人民衛(wèi)生出版社,2012:241-256.
[25] 李楊,馮世慶.早期股骨頭缺血性壞死治療:髓芯減壓并鉭棒優(yōu)于并植骨[J].中國組織工程研究,2014,18(5):815-820.
[26] 魏景梅,孫永強(qiáng),張淑霞.髓芯減壓加支撐術(shù)治療成人股骨頭缺血性壞死[J].中醫(yī)正骨,2007,19(10):36.
[27] 陳衛(wèi)衡,謝斌,劉道兵,等.髓芯減壓植骨術(shù)治療股骨頭壞死臨床療效的動(dòng)態(tài)研究[J].中華關(guān)節(jié)外科雜志(電子版),2014,8(5):578-584.
相似文獻(xiàn)/References:
[1]陳雷雷,張穎.何偉教授采用中醫(yī)藥療法治療股骨頭壞死的經(jīng)驗(yàn)[J].中醫(yī)正骨,2015,27(10):74.
[2]徐西林,趙永蘭,張曉峰,等.活骨注射液髖關(guān)節(jié)腔灌注對(duì)兔股骨頭壞死模型
血管內(nèi)皮生長因子表達(dá)的動(dòng)態(tài)影響[J].中醫(yī)正骨,2015,27(08):1.
XU Xilin,ZHAO Yonglan,ZHANG Xiaofeng,et al.Dynamic effect of intra-articular hip injection of Huogu injection on the expression of vascular endothelial growth factor in rabbit models with femur head necrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):1.
[3]周勇,任菲菲,豐凡翔,等.血管內(nèi)皮生長因子和骨形態(tài)發(fā)生蛋白2
在非創(chuàng)傷性股骨頭壞死不同區(qū)域的表達(dá)[J].中醫(yī)正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):7.
[4]鮑榮華,王國平,夏曉斌,等.鉭棒植入治療非創(chuàng)傷性股骨頭壞死的療效觀察[J].中醫(yī)正骨,2015,27(02):28.
[5]張兵,馬凰富,劉波,等.非創(chuàng)傷性股骨頭壞死的舌象定量研究[J].中醫(yī)正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):8.
[6]李剛,程春生.股骨頭壞死血瘀證癥狀與平樂郭氏正骨方藥藥物組成
最大頻繁關(guān)聯(lián)模式挖掘[J].中醫(yī)正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(01):21.
[7]李文龍,梅沉成,杜貴強(qiáng),等.微創(chuàng)減壓植骨多孔鉭棒植入治療
ARCOⅡ期非創(chuàng)傷性缺血性股骨頭壞死[J].中醫(yī)正骨,2016,28(02):43.
[8]張磊,金紅婷,童培建.骨健口服液早期干預(yù)非創(chuàng)傷性股骨頭壞死的臨床研究[J].中醫(yī)正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):14.
[9]鮑榮華,王國平,夏曉斌,等.直接前入路微創(chuàng)全髖關(guān)節(jié)置換術(shù)治療晚期股骨頭壞死[J].中醫(yī)正骨,2016,28(03):61.
[10]張超,姚晨,沈計(jì)榮.微創(chuàng)髓芯減壓打壓支撐植骨術(shù)結(jié)合補(bǔ)腎活血湯口服治療ARCOⅡ、Ⅲ期股骨頭壞死的近期療效觀察[J].中醫(yī)正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(01):20.
[11]陳衛(wèi)衡.中國股骨頭壞死數(shù)據(jù)庫的現(xiàn)狀與挑戰(zhàn)[J].中醫(yī)正骨,2020,32(01):1.
[12]雷志強(qiáng),曾平,陳衛(wèi)衡,等.中國股骨頭壞死數(shù)據(jù)庫股骨頭壞死流行病學(xué)特點(diǎn)分析[J].中醫(yī)正骨,2020,32(01):4.
[13]周占國,郭浩山,關(guān)濤,等.股骨頭壞死病因的相關(guān)因素分析[J].中醫(yī)正骨,2020,32(01):7.
[14]陳瑞,董博,袁普衛(wèi),等.股骨頭壞死誤診原因分析[J].中醫(yī)正骨,2020,32(01):11.
[15]楊琪,杜炯,孫繼高,等.股骨頭壞死中醫(yī)證型分析[J].中醫(yī)正骨,2020,32(01):14.
[16]曹玉舉,崔朋濤,孫繼高,等.不同ARCO分期和中日友好醫(yī)院分型股骨頭壞死的中醫(yī)證型分布特征研究[J].中醫(yī)正骨,2020,32(01):18.
[17]莊至坤,郭金花,趙巖,等.股骨頭壞死髖關(guān)節(jié)疼痛和活動(dòng)度與ARCO分期的相關(guān)性分析[J].中醫(yī)正骨,2020,32(01):21.
[18]范亞楠,李文龍,張穎,等.不同病因股骨頭壞死的ARCO分期和中日友好醫(yī)院分型特征研究[J].中醫(yī)正骨,2020,32(01):25.
[19]高歡歡,王向鵬,任浩,等.股骨頭壞死的舌象特征研究[J].中醫(yī)正骨,2020,32(01):28.
[20]薛志鵬,李記天,高歡歡,等.股骨頭壞死舌象特點(diǎn)的聚類分析[J].中醫(yī)正骨,2020,32(01):32.